Literature DB >> 17293360

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.

Imke Metz1, Claudia F Lucchinetti, Harry Openshaw, Antonio Garcia-Merino, Hans Lassmann, Marc S Freedman, Harold L Atkins, Biagio Azzarelli, Oldrich J Kolar, Wolfgang Brück.   

Abstract

The present study analyses autopsy material from five multiple sclerosis patients who received autologous stem cell transplantation. A total of 53 white matter lesions were investigated using routine and immunohistochemical stainings to characterize the demyelinating activity, inflammatory infiltrates, acutely damaged axons and macrophages/microglial cells. We found evidence for ongoing active demyelination in all of the five patients. The inflammatory infiltrate within the lesions showed only very few T cells and CD8+ cytotoxic T cells dominated the T cell population. B cells and plasma cells were completely absent from the lesions. High numbers of acutely damaged axons were found in active lesion areas. Tissue injury was associated with activated macrophages/microglial cells. The present results indicate that ongoing demyelination and axonal degeneration exist despite pronounced immunosuppression. Our data parallel results from some of the clinical phase I/II studies showing continued clinical disease progression in multiple sclerosis patients with high expanded disability system scores despite autologous stem cell transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17293360     DOI: 10.1093/brain/awl370

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  34 in total

1.  Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.

Authors:  S J Crocker; R Bajpai; C S Moore; R F Frausto; G D Brown; R R Pagarigan; J L Whitton; A V Terskikh
Journal:  Neuropathol Appl Neurobiol       Date:  2011-10       Impact factor: 8.090

Review 2.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

3.  [Recent advances in the pathogenesis and immunotherapy of multiple sclerosis].

Authors:  R Gold; P Rieckmann
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

4.  Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype.

Authors:  Martin Stangel
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

Review 5.  [Stem cell therapy in multiple sclerosis: a clinical update].

Authors:  S Schippling; R Martin
Journal:  Z Rheumatol       Date:  2009-05       Impact factor: 1.372

Review 6.  [Current value of stem-cell transplantation in autoimmune diseases].

Authors:  I Kötter; M Schmalzing; J Henes; W Vogel; L Kanz
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

7.  Stem cell transplantation for autoimmune diseases.

Authors:  Thomas Hügle; Thomas Daikeler
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

Review 8.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

Review 9.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

10.  Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.

Authors:  Christel Steen; Nadine Wilczak; Johannes M Hoogduin; Marcus Koch; Jacques De Keyser
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.